Safety of Capsule Endoscopy in Patients With Implantable Cardiac Devices

Yonsei University6 enrolled

Overview

This is a prospective study designed to assess safety and potential influence of the MiroCam on cardiac pacemaker and implantable cardiac defibrillator.

MiroCam (IntroMedic, Ltd, Seoul, Korea) is a small bowel capsule endoscope using human body communication for data transmission. There is a concern of potential interactions between cardiac devices and capsule endoscope. This clinical study was designed to evaluate the potential influence of the MiroCam on cardiac pacemaker and implantable cardiac defibrillator.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Gastrointestinal Disease Anemia

Eligibility

Sex: ALLMin age: 20 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. age 20 years or older 2. cardiac pacemaker or implantable cardiac defibrillator 3. gastrointestinal disease Exclusion Criteria: 1. previous GI perforation or obstruction history 2. known or suspected GI stricture 3. marked GI dysmotility 4. uncompensated heart failure (EF ≤30% or Killip's classification class ≥ III) 5. pregnancy

Locations (1)

Severance Hospital

Seoul, South Korea

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.